Home > HP (current issue) > News and features / News Centre | Search

PJ Online homeHospital Pharmacist
Vol 11 No 10 p406
November 2004

Hospital Pharmacist back issues

News summary


Tackling MRSA: more plans launched, but death rates could be underestimates

MRSA at BPC

Delegates at the British Pharmaceutical Conference heard how pharmacy staff have roles to play in fighting MRSA (p435)

Cleanliness a top priority

Hospital cleanliness is to be a top prioity for the new Chief Nursing Officer, Chris Beasley. Before taking up the CNO position, Ms Beasley held a number of nursing jobs in hospitals and the community and has worked for the NHS Modernisation Agency.

New moves to tackle methicillin-resistant Staphylococcus aureus and other hospital-acquired infections have been announced recently by the Department of Health. The strategies come at the same time as a patient support group suggests that death rates from hospital-acquired infections are considerably higher than those set out in the National Audit Report.

Among the Department of Health’s initiatives is an action plan for improving cleanliness in hospitals (a matron’s charter), launched on 19 October at the Middlesex Hospital, part of the University College London Hospitals Foundation Trust. It sets out ten key commitments, including that nurses and infection control teams are to be involved in drawing up cleaning contracts for hospitals and that matrons are to have the power to withhold payment where the services provided have been inadequate. Matrons are also to ensure that the importance of cleaning is recognised and that cleaning staff are made to feel a part of the ward team.

In addition, trusts also need to ensure that specific roles and responsibilities for cleaning are clear and that cleaning routines are agreed and well-publicised. All staff working in health care are to receive education about infection control and sufficient resources are to be dedicated to keeping hospitals clean.Patients are to be advised that they have a part to play in monitoring and reporting on standards of cleanliness.

In another development, NHS directors of infection prevention and control were brought together for the first time last month at conferences in London and Leeds to be briefed on their responsibilities for reducing MRSA rates. Their roles are to include ensuring the sterility of invasive equipment such as catheters as well as challenging prescribing decisions.

Organisations providing NHS services have already been informed in the “Winning ways” document that they each need to have a director of infection prevention and control, who is to report directly to trust chief executives and boards.

Such initiatives to counter MRSA assume an even greater significance in the light of a suggestion by a patient group that Government figures for death rates attributable to hospital-acquired infection are out of date. According to Tony Field, chairman of MRSA Support, the figure of 5,000 deaths per year stated in the National Audit Office report is based on data from a decade ago. The group’s own figures result from an analysis of official statistics, and indicate that hospital-acquired infection causes about 20,000 deaths per year, with approximately half of these being directly attributable to MRSA, he said. Mr Field added that he would like to see disinfectants used instead of detergents for hospital cleaning.

Back to Top


©The Pharmaceutical Journal